Update on Recurrent Respiratory Papillomatosis

Area of Science:

• Otolaryngology
• Pediatric Neoplasms
• Viral Diseases

Background:

• Recurrent respiratory papillomatosis (RRP) is the most common benign laryngeal neoplasm in children.
• RRP presents a significant challenge due to high recurrence rates and multisite involvement.
• The disease imposes a substantial burden on patient quality of life and incurs high healthcare costs, estimated at $120 million annually in the US.

Purpose of the Study:

• To summarize the current understanding of RRP's natural history.
• To review the quality of life impact of RRP.
• To highlight advancements in RRP prevention and treatment.

Main Methods:

• Literature review of RRP natural history.
• Analysis of quality of life data in RRP patients.
• Summary of basic science research in RRP prevention and treatment.

Main Results:

• RRP is characterized by frequent recurrence and affects multiple sites.
• Patients with RRP experience a significant decrease in quality of life.
• Significant healthcare costs are associated with managing RRP.

Conclusions:

• RRP remains a challenging condition with a notable impact on patients and healthcare systems.
• Further research into prevention and treatment is crucial for managing RRP.
• Understanding RRP's natural history and quality of life burden is key to improving patient outcomes.